Jim McMahon

Jim McMahon currently serves as Corporate Controller at Kiniksa Pharmaceuticals since July 2023. Previously, McMahon held positions at Pear Therapeutics from August 2021 to July 2023, including Director of Accounting and Director of SEC Reporting and Technical Accounting. Prior experience includes over 13 years at Ernst & Young as a Senior Manager in the Financial Services Office, where McMahon supported external audits and advisory services for various financial services companies, leading global audits and providing expertise in accounting change and internal controls. Academic credentials include a Master of Science in Accounting and a Bachelor of Business Administration in Accounting, both from the University of Notre Dame.